Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Nonarteritic anterior ischemic optic neuropathy after rapid weight loss during semaglutide therapy: a case report
Korean journal of family medicine, 2026;47(5):460-464
Switching from glucagon-like peptide-1 receptor agonists to tirzepatide in type 2 diabetes: does therapeutic sequencing matter for metabolic dysfunction-associated steatotic liver disease?
Journal of diabetes and its complications, 2026;:109418
Exploratory Biomarker-Defined Phenotypic Heterogeneity Beyond a Single Physiological Reserve Construct
Journal of personalized medicine, 2026;16(9)
Evaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes
Obesity pillars, 2026;20:100333
Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards
International journal of pharmaceutical compounding;30(4):329-336
Comparing Cardiovascular Outcomes in New Users of Oral Semaglutide Versus Other Noninsulin Glucose-Lowering Therapies Among Adults with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
Effects of semaglutide on subclinical cardiovascular health in people with HIV
AIDS (London, England), 2026
Nutritional Deficiencies, Complications, and Nutrition Therapy/Counseling in Pediatric Patients Using GLP-1 Receptor Agonists
Childhood obesity (Print), 2026;:21532176261486979
Semaglutide and Limb Events: Expanding the Cardiovascular Prevention Paradigm?
European journal of preventive cardiology, 2026
Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease
Diabetes, obesity & metabolism, 2026
Simultaneous and recurrent hordeola and chalazia associated with tirzepatide therapy: a case series
JCEM case reports, 2026;4(10):luag284
Preferences for Obesity Medications Among People With Overweight or Obesity in the United States: A Discrete-Choice Experiment (OPTIC)
Diabetes, obesity & metabolism, 2026
Semaglutide in Bipolar Disorder: A Differential Finding Needs a Differential Mechanism
Acta psychiatrica Scandinavica, 2026
Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
Effect of GLP-1 receptor agonist on nutrient intake: A narrative review
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2026
Do Preoperative Glucagon-Like Peptide-1 Receptor Agonists Influence Lumbar Fusion Outcomes? A Systematic Review and Meta-Analysis
International journal of spine surgery, 2026
Semaglutide as adjunct treatment for obesity in adolescents receiving antipsychotic medication (the GOAL trial): protocol for a single-arm, open-label feasibility study
BMJ open, 2026;16(9):e123779
The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia?
Medical sciences (Basel, Switzerland), 2026;14(5)
Predictors of treatment response to semaglutide for weight management
Frontiers in endocrinology, 2026;17:1893511
De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
Cureus, 2026;18(9):e116412